Alkermes plc. Acquisitions, Net of Cash Acquired
Alkermes plc. (ALKS) reported Acquisitions, Net of Cash Acquired of $2.09 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-07-28
- Alkermes plc. payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-30 was $0.00.
- Alkermes plc. payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was $2.09B.
- Alkermes plc. payments to acquire businesses, net of cash acquired for the quarter ending 2012-03-31 was $0.00.
- Alkermes plc. payments to acquire businesses, net of cash acquired for the quarter ending 2011-12-31 was -$188.00K.
- Alkermes plc. payments to acquire businesses, net of cash acquired for fiscal 2019 was $8.88M.
- Alkermes plc. payments to acquire businesses, net of cash acquired for fiscal 2012 was $494.77M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $2.09B 10-Q · filed 2026-07-28 | ||
| 2026-03-31 | $2.09B 10-Q · filed 2026-05-05 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 | |||
| 2019-12-31 | $8.88M 10-K · filed 2022-02-16 | |||
| 2012-03-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | -$188.00K derived: sum of 2 quarters · filed 2014-02-27 | $494.77M 10-KT · filed 2014-02-27 | |
| 2011-12-31 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $494.77M 10-Q · filed 2013-01-31 | ||
| 2011-09-30 | $494.96M 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |